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Abstract
It is generally assumed that inflammation following diethylnitrosamine (DEN) treatment promotes development of
hepatocellular carcinoma (HCC) through the activity of intrahepatic macrophages. However, the tumor-promoting
function of macrophages in the model has not been confirmed by either macrophage depletion or selective gene
depletion in macrophages. Here we show that targeted mutation of Cd24 dramatically increased HCC burden while
reducing intrahepatic macrophages and DEN-induced hepatocyte apoptosis. Depletion of macrophages also
increased HCC burden and reduced hepatocyte apoptosis, thus establishing macrophages as an innate effector
recognizing DEN-induced damaged hepatocytes. Mechanistically, Cd24 deficiency increased the levels of p53 in
macrophages, resulting in their depletion in Cd24−/− mice following DEN treatment. These data demonstrate that the
Cd24–p53 axis maintains intrahepatic macrophages, which can remove hepatocytes with DNA damage. Our data
establish a critical role for macrophages in suppressing HCC development and call for an appraisal of the current
dogma that intrahepatic macrophages promote HCC development.
Introduction
Hepatocellular carcinoma (HCC) is the third most
common cause of cancer-related deaths worldwide. Major
risk factors for HCC include hepatitis B virus (HBV) and
hepatitis C virus, aflatoxin B1, nonalcoholic steatohepati-
tis, chemical carcinogens (alcohol and nitrosamines) and
genetic factors1–3. Accumulating epidemiological and
clinical studies have provided convincing evidence that
HCC is an inflammation-related cancer as >90% of HCCs
are known to arise in the context of inflammation4,5.
Tumor-associated macrophages (TAMs) are a major
component of the leukocytes infiltrating in tumors. The
prevailing view is that TAMs have a critical role in pro-
moting carcinogenesis and is based on several lines of
clinical observations. First, increased TAM numbers
correlate with angiogenesis, metastasis, and thus poor
prognosis6–9. Consistent with this notion, activated
monocytes/macrophages in the peritumoral stroma of
HCC may promote angiogenesis and metastasis by
expanding Th17 and IL-17-producing CD8+ T cells (Tc17
cells)10–12. Second, TAM numbers correlate with intra-
tumoral regulatory T cells in HCC patients13,14. Third,
increased expression of PD-L1 in Kupffer cells (KCs) or
activated monocytes /macrophages is thought to con-
tribute to the suppression of tumor-specific T-cell
immunity in HCC tissues15,16. Fourth, monocytes/mac-
rophages render natural killer cells dysfunctional in HCC
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through CD48/2B4 interaction17. Fifth, elevated serum
levels of IL-6 have been frequently observed in patients
with HCC18.
Corresponding with the clinical observations, data from
several lines of preclinical investigations involving die-
thylnitrosamine (DEN)-induced HCC in mice are also
consistent with an HCC-promoting function of inflam-
mation and TAMs. For example, although deletion of the
IKKb gene in hepatocytes markedly enhanced DEN-
induced HCC, its deletion in both hepatocytes and leu-
kocytes suppressed HCC development19,20. Although
reduced NF-kβ activation in intrahepatic macrophages
was proposed as the underlying mechanism for reduced
HCC development, lineage-specific deletion was not
technically possible to validate the hypothesis19. Likewise,
IL-6, a major inflammatory cytokine, promoted tumor-
igenesis, and induced the expansion of cancer stem cells
by activating the STAT3 signaling pathway21,22. Il-6−/−
mice or mice with selective IL-6 ablation in leukocytes
exhibited a significant reduction of HCC development
and eliminated the gender bias in liver cancer23,24. Again,
although the genetic defect was attributed to intrahepatic
macrophages, such selective deletion cannot be achieved
based on the experimental design. Therefore, the putative
contribution of intrahepatic macrophages to HCC carci-
nogenesis deserves further investigation.
Paradoxically, targeted mutation of key regulators of
inflammatory responses, such as the Tlr2 and Tlr4 genes,
which reduces intrahepatic inflammatory responses, has
been shown to dramatically promote DEN-induced
HCC25,26, although several groups reported that germ-
line deletion of either Tlr4 or Tlr2 decreased HCC
development27,28. The Tlr4 mutation appears to affect
DNA damage and repair as the expression of Ku70 was
also reduced25. DNA damage occurs at an early stage of
carcinogenesis in normal parenchyma liver cells29. While
the cell-intrinsic mechanisms could repair DNA damage
or eliminate cells with unrepaired damage30, the innate
immune system may also eliminate cells with DNA
damage31 or alter DNA repair through unspecified
mechanisms25. These data raised the intriguing possibility
that the innate immune system may protect against DEN-
induced HCC carcinogenesis.
CD24 is a glycosylphosphatidylinositol (GPI)-anchored
cell surface protein with a broad expression in hemato-
poietic cells and cancer cells32. Cd24 acts as a costimu-
latory molecule to promote adaptive immunity including
autoimmunity33–37, but represses innate immune
response to liver injuries caused by acetaminophen38.
Given the role for Cd24 in regulating of inflammation to
liver injuries38, we investigated the impact of Cd24 dele-
tion on HCC carcinogenesis. Surprisingly, targeted
mutation of Cd24 reduced the number of F4/80+ cells and
reduced F4/80+ cell-mediated apoptosis of hepatocytes,
resulting in markedly increased host susceptibility to
DEN-induced HCC. Consistent with a protective function
of macrophages against HCC carcinogenesis, we show
depletion of macrophages at DEN induction, or 5 months
after induction, increased the incidence and tumor size of
HCC. Our data provide a new model on the evolving
function of macrophages during HCC pathogenesis and
call for the prevailing view of macrophage function in
DEN-induced HCC to be re-evaluated.
Results
Targeted mutation of Cd24 promotes
hepatocarcinogenesis
To investigate the role for Cd24 in DEN-induced car-
cinogenesis, Cd24−/− mice and their WT littermates were
injected with 15 μg/g DEN on day 15 after birth. Previous
studies revealed no spontaneous liver dysfunction or HCC
in Cd24−/− mice for up to 2 years39. Within 8 months of
DEN treatment, almost all the Cd24−/−male mice (37/38)
developed typical HCC, whereas only 76.5% of WT male
mice (26/34) bore tumors (Fig. 1a). Gross anatomy
(Fig. 1b) and Haematoxylin and eosin (H&E) analysis
(Fig. 1c) revealed that targeted mutation of Cd24 drasti-
cally increased the number and the size of HCC lesions.
At 8 months, liver weights were significantly increased in
Cd24−/− mice (2.5± 0.2 g) compared with those in WT
mice (1.8± 0.1 g) (p= 0.0002) (Fig. 1d). The increase in
liver weight is attributable to increased tumor size, as the
diameters of the largest tumors in Cd24−/− mice (7.7±
0.9) were nearly twice as those in the WT littermates (4.4
± 0.7) (p= 0.0057) (Fig. 1e). Moreover, the numbers of
observable HCC lesions were significantly higher in
Cd24−/− mice (9.8± 1.2) than in WT mice (2.7± 0.5) (p
< 0.0001) (Fig. 1f). When all tumors from one mouse were
combined, Cd24−/− mice bore a 5.1-fold larger tumor
volume than WT mice (844.8± 219.3 vs 166.4± 64.4, p=
0.0002) (Fig. 1g). To further evaluate the impact of the
Cd24 deletion on HCC onset and progression, we killed
mice at 4 and 7 months. As shown in Fig. 1h, at 4 months,
only 1/15 WT mice developed HCC, whereas 4/13
Cd24−/− mice developed visible HCC. While essentially
all Cd24−/− mice had visible tumors at 7 months in this
experiment, Cd24−/− livers had more tumors than WT
livers, as measured either by the numbers of observable
HCC lesions (Fig. 1i) or by the total tumor volumes
(Fig. 1j).
High-power histology analyses revealed that in addition
to the differences in tumor sizes and incidences, Cd24
deficiency increased malignancy of liver tumors
(Fig. 1k–m). At 8 months after DEN treatment, tumor
cells found in WT mice were benign as the nuclei/cyto-
plasm ratios are small (Fig. 1k). In contrast, the tumor
cells in the Cd24-deficient mice exhibit large and pleo-
morphic nuclei (Fig. 1l). Moreover, trabecular carcinoma
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Fig. 1 Targeted mutation of Cd24 promotes the development of HCC carcinogenesis. a Incidence of HCC tumors (diameter ≥1.0 mm) in male
WT (n = 34) and Cd24−/− (n = 38) mice 8 months after 15 μg/g DEN administration to 15-day-old mice. b Representative gross liver anatomy of 8-
month-old DEN-treated male WT (left) and Cd24−/− mice (right). c Haematoxylin and eosin (h&e) staining of liver sections (scale bar = 1 mm) in 8-
month-old DEN-treated male WT (left) and Cd24−/− mice (right). Black dash lines indicate border of the tumor nodules. d–g Liver weight d, maximum
tumor diameters e, numbers of ≥1.0 mm visible tumors per mouse f, and total tumor volumes g in male mice 8 months after DEN (15 µg/g) injection.
Data are pooled from multiple experiments. h–j Incidence of mice with liver tumors h, tumor numbers i, total tumor volumes j in male mice at the
4th or 7th month after DEN (15 µg/g) injection. Two pooled independent experiments. Data represent means. *p < 0.05, **p < 0.01, ***p < 0.001, using
two-tailed, unpaired Student’s t-test e–g, h–j or Mann–Whitney test d. k–m High power (× 40) H&E image of tumor nodules in livers from WT k and
Cd24−/− l, m mice. Note benign morphology of WT adenoma cells k, pleomorphic nuclei and trabecular carcinoma l and leukocyte infiltrationm into
Cd24−/− HCC. Data shown are sections prepared at 8 months after DEN treatment
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(Fig. 1l) and lesions with lymphocyte infiltration (Fig. 1m)
were also found in some tumors from the Cd24−/− mice.
Apart from alteration in cellular morphology, we also
observed extensive architecture changes in tumors from
Cd24−/− but not WT mice (Supplementary Figure S1).
These include ductules extending to the peripheries of
foci lesions and associated with bile ducts (Supplementary
Figure S1a, black arrow), foci of lesions penetrated into
the walls and proliferated in the lumens of a hepatic vein
branch (Supplementary Figure S1b, red arrow), and vas-
cularization by portal vein branches (Supplementary Fig-
ure S1c, blue arrow). These features further support the
idea that Cd24 deficiency promotes HCC development.
The striking impact of germline deletion of the Cd24 gene
in HCC onset and progression suggests that Cd24 is a
critical repressor for carcinogenesis of HCC.
Reduction in acute inflammation and hepatocyte
apoptosis in Cd24−/− mice
Reactive oxygen species (ROS) are the major effector
molecules produced by neutrophils and activated mac-
rophages40,41. As the first test to evaluate the effect of
acute inflammation on HCC, we evaluated the levels of
ROS in WT and Cd24−/− liver sections. As shown in
Fig. 2a and quantified in Fig. 2b, whereas comparable
levels of ROS staining were found in WT and Cd24−/−
livers from control mice that received no DEN, Cd24−/−
sections showed much reduced ROS signals 24 h after
DEN administration. Interestingly, although ROS+ cells in
the untreated groups and those isolated from 1 and
4 months after DEN treatment had the morphology of
hepatocytes (Supplementary Figure S2), immediately after
DEN treatment they became mostly mononuclear cells
based on the cellular size. Therefore, reduction in ROS
levels in the Cd24−/− mice may reflect a reduction in
inflammation. In addition, we also evaluated ROS-
induced DNA damage based on the analysis of γ-H2AX
expression in liver tissues. Our data demonstrated that
Cd24−/− mouse livers showed a significant decrease in γ-
H2AX levels when compared with WT mouse livers
(Fig. 2c, d).
As ROS is a major mediator for the induction of
apoptosis, we evaluated apoptosis in liver sections using
TUNEL staining. As shown in Fig. 2e, f, DEN-treated WT
liver sections contained a high number of apoptotic
hepatocytes on day 1 after DEN treatment. This number
is much lower in the Cd24−/− liver sections. To evaluate if
ROS is responsible for the death of hepatocytes, we pre-
treated mice with hydroxyanisole (BHA) to quench ROS
and then measured the number of TUNEL+ cells at 24 h
after DEN treatment. As shown in Supplementary Fig-
ure S3, BHA reduced the percentage of apoptotic cells in
the WT but not Cd24−/− cells. Therefore, the elevated
ROS in the WT mice contributed to increased apoptosis
of liver cells one day after DEN administration.
Recent studies have shown that depletion of adaptive
immune cells promotes formation and progression of
DEN-induced liver cancer42. In order to determine the
potential role of immune cells in HCC initiation, we iso-
lated liver mononuclear cells and analyzed the phenotype
of inflammatory cells in the livers of Cd24−/− and WT
mice by FACS analysis. We found that CD11b+ (Sup-
plementary Figure S4A and B) were increased in WT but
not in Cd24−/− mice after DEN treatment. In contrast,
the percentage of T cells, including both CD4 and CD8
T cells, was significantly higher in Cd24−/− livers than in
that of WT mice, with or without DEN treatment (Sup-
plementary Figure S4C and D). Higher levels of adaptive
responders may also contribute to increased
carcinogenesis.
Importantly, as shown in Fig. 3a, b, although the per-
centage of macrophages/KCs (F4/80+CD11b+) was
increased in DEN-treated WT livers, DEN treatment
failed to increase the frequency of macrophages in
Cd24−/− livers. A more marked difference was observed
by immunohistochemistry (IHC) analysis, which revealed
nearly threefold reduction in F4/80+ cells from Cd24−/−
livers on day 1 after DEN treatment compared with WT
livers (Fig. 3c, d). The reduction is transient as it is not
observed on day 30 and beyond when F4/80+ cell num-
bers in WT liver return to lower levels (Fig. 3c, d). Based
on markers used in previous studies43, we further
(see figure on previous page)
Fig. 2 Cd24 deficiency reduces ROS production and apoptosis of hepatocytes. Liver tissues were isolated at 24 h after 15 μg/g DEN injection
into 15-day-old male mice for histological staining. a and b Liver cryosections were incubated with 2 μM dihydroethidine for 30 min at 37 °C. Cells
staining positive (red) for the oxidized dye were identified by fluorescence microscopy a and quantified by Image-Pro Plus 6.0 software b. At least 10
fields from different mice were counted. Data from two independent experiments are pooled (Control mice: n = 9; DEN-mice: n = 19 or 23). c γ-H2A.X
staining for DNA damage in DEN-treated mice. Liver sections were obtained at 24 h after DEN treatment. d Relative Integrated optical density (IOD) of
γ-H2A.X-positive cells quantified by Image-Pro Plus 6.0 software. At least three slides from successive sections of different mice were analyzed. Data
from two independent experiments are pooled (n = 23 or 25). e Representative liver sections stained by the TUNEL assay. f Average numbers of
TUNEL-positive cells in a high-power field of a fluroscerence microscope. At least five fields from different mice were counted. Data represent the
representative experiments from three independent experiments (Control mice: n = 4; DEN-mice: n = 6).. Scale bar = 100 μm. The data were analyzed
by Student’s t-test. Data are means
Li et al. Cell Discovery  (2018) 4:6 Page 5 of 19
identified, by FACS analysis, the percentage of liver-
resident KCs (defined as F4/80+CD11bloLy6Clo). We
found that it was increased following DEN treatment in
WT livers but not in Cd24−/− livers (Supplementary
Figure S5A and B). In contrast, the percentage of
monocyte-derived macrophages (MoMs, defined as F4/
80+CD11bhiLy6Cint) was not obviously changed in either
WT or Cd24−/− livers following DEN treatment (Sup-
plementary Figure S5A and C). These data revealed
selective decrease of the intrahepatic KCs in the Cd24−/−
mice shortly after DEN treatment. However, whereas both
flow cytometry result of isolated mononuclear cells and
IHC analysis of liver sections revealed the impact of Cd24
deletion on acute inflammatory cells, only IHC reveals a
net reduction of intrahepatic macrophages in Cd24−/−
livers after DEN treatment. This is perhaps owing to an
uneven loss of F4/80+ cells during FACS isolation of
mononuclear cells in different groups. Despite of the
subtle differences, both methods reveal a critical role for
Cd24 in the maintenance of high numbers of intrahepatic
F4/80+ cells in DEN-treated mice at the time of DEN
induction.
To substantiate the contribution of Cd24 to acute
inflammation, we measured the amounts of Il-6, Il1b,
Tnfa, and Mcp-1 transcripts in untreated and DEN-
treated mice. As shown in Fig. 3e, whereas elevation of Il-
6, Il1b, and Tnfa transcripts was observed following DEN
treatment in WT livers, no increase was found in the
Cd24−/− livers. Reduction of IL-1β protein was also
observed in the Cd24−/− livers upon DEN treatment
(Supplementary Figure S6A). However, Cd24 deletion had
no effect on the expression of Mcp-1 after DEN admin-
istration (Supplementary Figure S6B). Corresponding to a
reduced inflammatory response, STAT3 phosphorylation
was reduced in Cd24−/− liver tissues after DEN admin-
istration (Supplementary Figure S6C). Furthermore,
although WT mice exhibited a significant increase in
serum HMGB1 levels at 24 h after DEN treatment (Sup-
plementary Figure S6D), no increase was found in the sera
from Cd24−/− mice. HMGB1 can be secreted actively by
activated leukocytes and released passively by necrotic
cells. As there were no significant changes in serum ALT
levels, a marker of acute liver toxicity after DEN injection
in WT and Cd24−/− mice (Supplementary Figure S6E), it
is more likely that the increased HMGB1 may be secreted
from activated leukocytes, but not necrotic hepatocytes.
We next addressed the effects of Cd24 deficiency in
chronic response. We detected a persistent increase in
ROS accumulation in livers of Cd24−/− mice compared
with WT livers 1 and 4 months after DEN administration
(Supplementary Figure S2A and B). However, compared
with WT mice after DEN treatment, Cd24−/− mice dis-
played a persistent decrease in cell apoptosis in liver as
marked by TUNEL staining (Supplementary Figure S7A
and B). In contrast, Cd24−/− livers showed a remarkable
increase in proliferation biomarker PCNA (proliferating
cell nuclear antigen) as indicated by IHC staining (Sup-
plementary Figure S7C and D). Except for IL-6, no sig-
nificant differences were observed between WT and
Cd24−/− mice for inflammatory cytokines (Supplemen-
tary Figure S7E). These results suggest that Cd24 defi-
ciency may promote HCC by protecting liver cells from
DEN-induced apoptosis and increasing cell proliferation.
Intrahepatic macrophages induce apoptosis of
hepatocytes and suppress hepatocellular adenoma in
DEN-treated mice
To determine whether DEN treatment induces iNOS
expression in macrophages, we isolated liver macro-
phages/KCs from DEN-treated mice. The purity of mac-
rophages after isolation was >90% based on
immunofluorescence microscopy result (Fig. 4a). A sig-
nificant increase in iNOS mRNA levels was observed in
DEN-treated WT intrahepatic macrophages (Fig. 4b). In
contrast, no increase was found in the livers of DEN-
treated Cd24−/− mice (Fig. 4c). Furthermore, we also
observed that liver macrophages/KCs resided in close
proximity to DNA-damaged cells identified by γ-H2AX
(Fig. 4d).
To further confirm that liver macrophages/KCs are
responsible for the hepatocyte apoptosis in DEN-treated
livers, WT and Cd24−/− mice were treated with control
liposomes or liposomal clodronate to deplete macro-
phages/KCs starting at 48 h before DEN injection. KCs are
depleted as early as 12 h after administration with
liposome-encapsulated clodronates, and repopulation
starts at the end of the first week44. As shown in Fig. 5a,
there was almost complete depletion of liver macrophages
in both WT and Cd24−/− mice. The depletion was also
confirmed by F4/80-encoding Emr1 mRNA levels
(Fig. 5b). Consistent with the published data44, depletion
of KCs suppressed the induced mRNA levels of Il1b and
Il6 and slightly increased the levels of Mcp-1 (Supple-
mentary Figure S8). TUNEL assay showed that liver
macrophage depletion resulted in diminished apoptosis in
DEN-treated WT livers, but had no effect on apoptosis in
Cd24−/− livers. Importantly, no significant differences
existed in the number of apoptotic cells between WT and
Cd24−/− livers after liver macrophages were depleted
(Fig. 5c, d). These data demonstrate that intrahepatic
macrophages are responsible for the hepatocyte apoptosis
in DEN-treated WT mice and that the reduction in
macrophages in the Cd24−/− livers is responsible for the
decreased hepatocyte apoptosis following DEN treatment.
To examine whether intrahepatic macrophage accu-
mulation in DEN-treated WT mice is involved in the
inhibition of tumor incidence and growth, clodronate-
containing or control liposomes were administered to WT
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mice to deplete intrahepatic macrophages 48 h before
DEN injection at 13 days of age. Mice in both groups were
kept for five additional months, after which they were
killed and analyzed to determine tumor burden. As
expected, at this early time point, no architectural
alteration was observed in tumors from either WT or
Cd24−/−, and the tumors were mostly hepatocellular
adenoma (Fig. 5e). However, the tumor cells in Cd24−/−
adenoma were considerably more advanced in malignant
transformation based on the nuclei/plasma ratio and by
the pleomorphic nuclei and the presence of mitotic tumor
cells (Fig. 5e). Summary data were presented in Fig. 5f–i.
As shown in Fig. 5f, clodronate administration markedly
increased the incidence of macroscopic liver adenoma
from 20% (3/15) to 75% (6/8). Furthermore, the ratio of
liver to body weight (Fig. 5g), number of tumors (Fig. 5h),
and maximum tumor sizes (Fig. 5i) were significantly
larger in clodronate-administrated WT mice than in the
control treated mice. These data indicate that intrahepatic
macrophage depletion at DEN induction promotes inci-
dence and growth of HCC.
Accumulating evidence indicates that macrophage
counts are significantly higher in peritumoral liver tissues
than in the corresponding intratumoral tissues45,46. By
immunohistochemical staining using an anti-F4/80 anti-
body, we confirmed the enhanced accumulation of mac-
rophages in peritumoral liver tissues during DEN-induced
hepatocarcinogenesis compared with intratumoral liver
tissues (Supplementary Figure S9). To further investigate
the role of intrahepatic macrophages after tumor forma-
tion, we depleted the intrahepatic macrophages using
liposomal clodronate 5 months after DEN treatment
when HCC was visible in some mice and killed the mice
one month later for analysis. The data were presented in
Fig. 5j–n. Histologically, the cells in the tumor nodules in
control liposome-treated mice lacked features of neo-
plastic transformation, as the nuclei were not significantly
enlarged and relatively uniform. In contrast, significant
heterogeneity was observed in the sizes of nuclei in ade-
noma in mice with macrophage depletion, and many of
the nuclei were pleomorphic (Fig. 5j), suggesting that
depletion of macrophages at 5 months could still accel-
erate malignant transformation of the hepatocellular
adenoma. Strikingly, the incidence of macroscopic liver
cancers in clodronate-treated mice was 87.5% (7/8),
whereas that in the control liposome group was only 9.1%
(1/11) (Fig. 5k). The number of tumors (Fig. 5l), maximal
tumor sizes (Fig. 5m), and total tumor volumes (Fig. 5n)
in clodronate-administrated mice were also much
increased when compared with control mice. These data
suggested that TAM also inhibit HCC progression.
Together, these data indicate that intrahepatic macro-
phage depletion at either at DEN induction or 5 months
after DEN induction promotes incidence and growth of
HCC, although the functions of macrophages at these
different timepoints were not necessarily the same. As
chronic treatment with clodronate could affect hepatocyte
function, it is not possible to continue the treatment until
the mice developed HCC. Inshort, intrahepatic macro-
phages have an important protective role against DEN-
induced HCC. It remains to be investigated whether the
protective functions of macrophages against HCC carci-
nogenesis are achieved through different mechanisms to
that in tumor-bearing mice at different times after DEN
treatment.
DEN treatment induces depletion of Cd24−/− macrophages
by a p53-dependent mechanism
To test whether apoptosis of intrahepatic macrophages
resulted in the decreased number of macrophages in
DEN-treated Cd24−/− mice, we carried out double
staining with anti-F4/80 antibody and TUNEL assay in
liver sections. At 24 h after DEN administration, more
apoptotic macrophages (F4/80+TUNEL+ cells) were
observed in DEN-treated Cd24−/− livers compared with
WT livers, in contrast to what was observed with the
apoptosis of non-macrophages (F4/80−TUNEL+ cells)
(Fig. 6a, b). To further confirm the increased sensitivity of
Cd24−/− macrophage to DEN treatment, we measured
the apoptosis and number of peritoneal macrophages 24 h
after DEN administration. As shown in Fig. 6c, a more
severe reduction in the number of peritoneal
(see figure on previous page)
Fig. 3 Cd24 deficiency reduces acute inflammation caused by DEN treatment. a, b Flow cytometry analysis (FACS) of intrahepatic F4/80+ cells.
Liver mononuclear cells were isolated 24 h after 15 μg/g DEN or 0.9% NaCl solution (as control) by intraperitoneal injection to 15-day-old mice for
FACS. a The data are representative FACS profiles. b Percentages of F4/80+CD11b+ cells among CD45+ cells in liver. Data are pooled from multiple
experiments involving age and gender matching mice. c and d Cd24 deficiency decreases the number of intrahepatic F4/80+ cells. Liver tissues were
isolated at the indicated timepoints after 15 μg/g DEN injection into 15-day-old mice for the F4/80 staining. The data in c are representative images
of F4/80 staining (scale bar = 100 µm), and those in d are the mean ± SEM. Integrated optical density of F4/80-positive cells quantified by Image-Pro
Plus 6.0 software in a low-power field of a microscopy. At least five fields each section were counted. Data are from one of two independent
experiments (Control: n = 5; DEN-mice: n = 9). e The inflammatory cytokine mRNA transcript levels were determined by Real-time PCR. Liver tissues
were isolated 24 h after 15 μg/g DEN injection into 15-day-old mice for cytokine measurement. Control: n = 5; DEN-mice: n = 11. Data are means ±
SEM, and are pooled from independent experiments
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macrophages was induced by DEN in Cd24−/− mice than
WT mice. Correspondingly, DEN induced the apoptosis
of peritoneal macrophages from Cd24−/− but not WT
mice (Fig. 6d, e).
DEN is a typical chemical carcinogen that causes DNA
damage and mutations once activated by cytochrome
P450 2E129. DNA damage induces the activation of p53
pathway to eliminate damaged cells30. Our recent pub-
lication showed that Cd24 disrupts ARF-NPM association
and reduces cellular p53 levels in cancer cells47. We
therefore analyzed Cd24 expression on liver cells, and
found Cd24 was expressed on hematopoietic cells, but not
hepatocytes or tumor cells of HCC and naive mice
(Supplementary Figure S10A and B). Flow cytometry
analysis revealed high levels of Cd24 on intrahepatic
macrophages as well as other leukocytes (Supplementary
Figure S10C and D), which raised the intriguing possibi-
lity that the CD24–p53 antagonism discovered in cancer
cells may regulate macrophage survival. In order to
determine whether Cd24 regulates p53 in macrophages,
we examined the expression of p53 and p53-regulated
genes in peritoneal macrophages following DEN treat-
ment. The purity of macrophages after isolation was
>90% based on immunofluorescence microscopy result
(Supplementary Figure S11A). As shown in Fig. 7a, p53
protein levels were elevated in both WT and Cd24−/−
macrophages after DEN treatment. However, Cd24−/−
macrophages expressed more p53 protein than WT
macrophages regardless DEN treatment (Fig. 7a). To
determine the functional consequence of p53 upregula-
tion, we measured the transcript levels of p21 and puma,
the prototypic target gene of p53, in DEN-treated mac-
rophages. As shown in Fig. 7b, mRNA level of p21 was
significantly higher in Cd24−/− macrophages, whereas no
obvious difference was found in puma expression
between WT and Cd24−/− macrophages (Supplementary
Figure S11B). To substantiate this observation, macro-
phages were isolated from naive WT and Cd24−/− mice
and then treated with DEN in vitro for 24 h. As shown in
Fig. 7c, Cd24−/− macrophages also exhibited higher levels
of p21 mRNA at 24 h after DEN administration relative to
WT macrophages that received the same treatment.
However, the mRNA levels of puma were not changed
after DEN administration, and no difference was observed
between WT and Cd24−/− mice (Supplementary Fig-
ure S11C). These data suggest that the effector that p53
target for apoptosis in macrophages is unlikely Puma. As
p21 is involved in senescence rather than apoptosis, the
p53 responsive target responsible for apoptosis remain to
be defined in this model.
To determine whether elevation of p53 is responsible
for apoptosis of macrophages, we produced Cd24−/−
Trp53−/−, Cd24+/+Trp53−/−, Cd24−/−Trp53+/+,
Cd24+/+Trp53+/+ mice by intercrossing mice with dele-
tion of either gene. We then treated 15-day-old male mice
with 15 μg/g DEN. Twenty-four hours later, intrahepatic
macrophages were assessed by IHC with anti-F4/80
antibody. Images of representative slides from one mouse
in each group are shown in Fig. 7d, whereas summary data
from 18 pairs of mice were summarized in Fig. 7e. As
expected, at 24 h after DEN injection, intrahepatic F4/80+
cells were significantly reduced in Cd24−/−Trp53+/+ mice
when compared with Cd24+/+Trp53+/+ mice. Remark-
ably, the impact of Cd24 was completely ablated with
Trp53 deletion (Cd24+/+Trp53−/−). Thus, loss of intra-
hepatic macrophages after DEN treatment of the Cd24−/−
mice is attributed to the upregulation of Trp53 gene.
Discussion
Based on the current paradigm that inflammation pro-
motes HCC carcinogenesis and the fact that carcinogen
DEN induces extensive death of hepatocytes5, we evaluated
the impact of targeted mutation of Cd24, which exacerbates
host response to cellular injuries38,48. Surprisingly, whereas
Cd24 deletion did increase susceptibility to HCC, it reduced
rather than increased inflammatory response to DEN. Our
in-depth analysis of this model revealed new insights on the
function of Cd24 in macrophages and the function of
intrahepatic macrophages on HCC pathogenesis.
Although a large body of circumstantial evidence is
consistent with the notion that intrahepatic macrophages
promote HCC development, the proposed cancer-
promoting function of macrophages has not been
established by either macrophage depletion or macrophage-
specific gene deletion. Here, we provide two lines of direct
evidence that argue against this prevailing view.
(see figure on previous page)
Fig. 4 Cd24 deficiency ablates acute iNOS accumulation in intrahepatic macrophages after DEN treatment. a Purity characterization of
isolated intrahepatic macrophages. The isolated liver mononuclear cells were incubated for 2 h to remove the non-adherent cells. The adherent cells
were used as source for intrahepatic macrophages that were stained with anti-F4/80 antibodies by immunocytochemical method. b, c Quantitative
RT-PCR of iNOS expression in isolated live macrophages/Kupffer cells from mice 24 h after 15 μg/g DEN injection at 15 days of age. b WT mice.
c Cd24−/− mice. The data were analyzed by Student’s t-test. Data from individual mice in two independent experiments are presented. d Liver
macrophages/Kupffer cells reside in close proximity to DNA-damaged cells identified by γ-H2AX. Representive photograph of F4/80 (brown) and γ-
H2AX (blue) double staining in frozen liver sections from mice 24 h after 15 μg/g DEN injection at 15 days of age. Red arrows indicate co-staining for
F4/80 and γ-H2AX
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First, macrophages are responsible for the apoptosis of
DEN-treated hepatocytes in vivo, some of which harbor
cancer-causing mutations. This function is suggested by
the correlation between the amounts of intrahepatic
macrophages and the amounts of hepatocyte apoptosis
and, more importantly, validated by in vivo depletion of
macrophages. As the depletion of macrophages sub-
stantially reduced hepatocyte apoptosis in DEN-treated
WT mice, our data demonstrate a role for macrophages in
inducing hepatocyte apoptosis. Considering DEN is a
known DNA damaging agent29, we suggest that during
acute inflammation, macrophages may reduce HCC risk
by eliminating cells with DNA damage. A similar function
has been suggested for NK cells by in vitro studies31.
Furthermore, macrophages have been shown to clear
precancerous senescent hepatocytes49. In addition, as
removing macrophages in the Cd24-deficient mice does
not affect the amounts of apoptotic cells, it is likely that
Cd24 deficiency has ablated the activity of intrahepatic
macrophages, either through functional inactivation or
through reduction in the number of intrahepatic
macrophages.
Second, depletion of macrophages at DEN induction, or
5 months after, substantially increased HCC carcinogen-
esis. Although the impact of macrophage depletion at
DEN induction suggests that removing cells with DNA
damage will likely reduce the chance of carcinogenesis,
the dramatic impact of macrophage depletion at five
months after DEN induction argues against the notion
that macrophages evolve into HCC-promoting M2-type
macrophages.
Although the focus of the current study was to establish
the functional significance of intrahepatic macrophages
rather than the mechanism of its effector function, our
data suggest some potential mechanisms for future stu-
dies. We showed that WT but not Cd24−/−mice had high
levels of ROS 1 day after DEN treatment. As the ROS+
cells are mononuclear cells rather than hepatocytes, and
ROS are known to be cytotoxic for DEN-treated hepato-
cytes, we suggest that elevation of ROS in WT mice (as
compared with Cd24−/− mice) provides an effector
mechanism for intrahepatic macrophages. The reduction
of ROS+ cells also explains the reduced hepatocyte
apoptosis in the Cd24−/− mice. Consistent with this
notion, we found that pre-treatment with butylated BHA
significantly reduced hepatocyte apoptosis in WT but not
Cd24−/− mice. Alternatively, we have observed much
higher levels of iNOS among intrahepatic macrophages in
WT mice when compared with Cd24−/− mice. As NO is a
known effector molecule produced by macrophages50,51,
the increase in iNOS not only provides another
mechanism by which intrahepatic macrophages induce
apoptosis of hepatocytes during DEN treatment, but also
suggests a possible role for Cd24 in the differentiation of
macrophages.
It should be pointed out that the surveillance function
of macrophages may be achieved by different mechanisms
at different stages of carcinogenesis. Although our data
suggested that in the early stage, macrophages help to
remove hepatocytes with DNA damage, how the macro-
phages that surround HCC lesions restrict their growth
remains to be investigated.
As outlined in the Introduction, the evidence that
supports the role for TAM in HCC human carcinogenesis
is based on their ability to either directly suppress CD4 T-
cell responses or indirectly induce Tregs that in turn
(see figure on previous page)
Fig. 5 Intrahepatic macrophages are responsible for increased apoptosis of WT but not Cd24−/− mouse livers and for suppression of HCC
development. To deplete liver macrophages, 13-day-old mice were injected i.p. with 70 μL of liposomal clodronate or control at 48 h before 15 μg/g
DEN administration. a F4/80 staining for liver macrophages following injection of control liposomes and clodronate liposomes into WT and Cd24−/−
mice. Scale bar = 100 μm. b mRNA levels of F4/80-encoding Emr1 were analyzed by RT-PCR. c Liver sections were analyzed by TUNEL assay. Scale bar
= 100 μm. d Average numbers of TUNEL-positive cells in a high-power field of a fluroscerent microscope. At least 10 fields from different section were
counted. Control liposomes: n = 8; Clodronate liposomes: n = 12. Representative data from one of two experiments are shown. The data were
analyzed by Student’s t-test. (e–i Depletion of macrophage at the time of DEN induction increases the incidence of HCC. Liver macrophages in 13-
day-old WT mice were depleted by injection i.p. with 70 µl of clodronate or control liposomes twice within 5 days. 48 h after the first injection of
liposomes, mice were treated with 15 µg/g DEN. Mice in both groups were kept for 5 additional months, after which they were killed and analyzed to
determine tumor load and morphology. (e Histology analyses revealed significant difference in neoplastic transformation of adenomas from control
liposome-treated (top panels) or clodronate-treated macrophage-depleted mice (bottom panels). The left panels show 10 × images, whereas the
right panels show high-power images. Note enlarged and pleomorphic nuclei in the adenoma from the macrophage-depleted mice. f Tumor
incidences (diameter ≥1.0 mm), g liver to body weight ratios, h tumor numbers, and i maximal tumor sizes are shown. Control liposomes: n = 15;
Clodronate liposomes: n = 8. Data from two pooled independent experiments are shown. j–n WT mice were injected with 15 μg/g DEN at 15-day of
ages. After 5 months, 200 μL of a 1:1 PBS-diluted liposomes were injected via the tail vein once every 5 days for a total of three times. All mice were
killed 1 month after the last injection. (j) Histology analyses revealed significant difference in neoplastic transformation of adenomas from control
liposome-treated (top panels) or clodronate-treated macrophage-depleted mice (bottom panels). The left panels show 10 × images, whereas the
right panels show high-power images. Note: more heterogenous, enlarged, and pleomorphic nuclei as well as mitosis (red arrow) in adenoma from
the macrophage-depleted but not control liposome-treated mice. (k) Tumor incidences (diameter ≥1.0 mm), l tumor numbers, m maximal tumor
sizes, and n total tumor volumes were shown. Control liposomes: n = 11; Clodronate liposomes: n = 8. The data were analyzed by Student’s t-test
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would reduce adaptive T-cell immunity52. It therefore
remains possible that when T-cell response is the key
determinant, macrophages may play a suppressive func-
tion. Alternatively, apart from the immune suppressive
features, the TAM in human HCC may also possess an
innate protective function as described herein. The ulti-
mate function of TAM would depend on the balance of
these two opposing forces. In the mouse DEN model,
however, all genetic studies supporting a role for macro-
phages in promoting tumor growth have used drivers that
cause deletion in all leukocytes and non-leukocytes19,20.
Therefore, these studies do not allow comparison with
our data presented herein. Much like other studies cited
herein, our model depends on one-time exposure to a
genotoxin and thus may differ somewhat from human
HCC carcinogenesis that likely results from chronic
exposure to toxic chemicals or chronic viral infection.
However, our work is more decisive in establishing a
surveillance function or macrophages in the DEN-
induced HCC model because we showed its function by
direct depletion. The relevance of Cd24 in human HCC
pathogenesis is supported by the fact that Cd24 poly-
morphism affects the risk and progression of HCC53,54.
Based on our recent studies in cancer cells, in which we
showed that Cd24 increases p53 levels through antagon-
ism with the ARF-MDM2 pathway47, we evaluated the
role for p53 in macrophages survival. Our genetic studies
clearly revealed that Trp53 is downstream of Cd24 in
regulating survival of intrahepatic macrophages. Our
genetic evidence provides a new concept that tumor
suppressor gene could regulate host immunity through its
impact on the survival of innate immune effectors. Apart
from the macrophage-intrinsic protective function, a large
body of evidence shows a costimulatory function of CD24
for T-cell activation34,36,55,56. Therefore in models in
which CD4 T cells promote cancer development, one may
expect a different consequence of targeted mutation of
the Cd24 gene. In this context, it would be of great
interest to reconcile the cancer-promoting function of the
Cd24 gene in HCC caused by a HBV transgene, as we
have reported54. Furthermore, given the expression of
CD24 on B cells and a potential role for B cells in HCC
pathogenesis57, it is of interest to investigate the function
of CD24 on B cells during HCC pathogenesis in the future
study.
Materials and methods
Experimental animals
Mice with the targeted mutation of Cd24 were produced
using embryonic stem cells from C57BL/6 mice as
described previously39. Trp53 mutant mice B6.129S2-
Trp53tm1Tyj/JNju (referred to as Trp53+/− mice)58 were
purchased from Nanjing Biomedical Research Institute of
Nanjing University. Trp53+/− mice were crossed with
Cd24−/− mice, and the offsprings were genotyped by
genomic polymerase chain reaction (PCR) to get the
Cd24+/−Trp53+/− mice. Then Cd24+/−Trp53+/− mice
were intercrossed to generate Cd24+/+Trp53−/−, Cd24−/−
Trp53−/−, Cd24+/+Trp53+/+, and Cd24−/−Trp53+/+ mice.
Cd24−/− and WT mice on a C57BL/6 background were
intercrossed to generate Cd24−/− mice and WT litter-
mates. The genotypes were determined by PCR. All of the
mice were maintained under specific pathogen-free con-
ditions in the animal facility at the Institute of Biophysics,
Chinese Academy of Sciences. All studies involving animals
were approved by the Institutional Laboratory Animal Care
and Use Committee.
Induction of HCC
Fifteen-day-old male mice were injected intraper-
itoneally (i.p.) with 15 μg/g DEN (Sigma), as indicated. For
the tumor initiation model, after 1, 4, 7, and 8 months on
normal chow, all mice were killed, and their livers were
removed. Externally visible tumors (≥1.0 mm) were
counted. The length (L) and width (W) of tumors were
measured by a vernier caliper. The tumor volume was
calculated by (L×W×W)/2. For the early effects of DEN,
mice were killed 24 h after DEN treatment and peritoneal
resident macrophages and liver tissues were collected.
The liver tissues were stored at −80 °C for protein isola-
tion, TRizol reagent (Invitrogen) for RNA extract, and
embedded in optimal cutting temperature compound
(see figure on previous page)
Fig. 6 Cd24 maintains macrophages at acute phase during DEN treatment. a and b Two-color immunofluorescence staining of frozen liver
tissue sections 24 h after mice received 15 μg/g DEN on the 15th day after birth. Representative liver sections stained with anti-F4/80 antibody and
TUNEL assay. a Apoptotic macrophages (yellow arrows) were F4/80+/TUNEL+ cells. Scale bar = 100 μm. b Average numbers of TUNEL-positive cells in
a high-power field of a fluroscerence microscope. At least 10 fields from difference mice were counted. N = 9. c–e Flow cytometry analysis of
peritoneal macrophages. 15-day-old mice were treated with 15 μg/g DEN and 24 h later, resident peritoneal cells were harvested by lavage of mouse
peritoneal cavity with 3% FCS/PBS. Peritoneal macrophages were stained with F4/80-FITC antibody and PE Annexin V Apoptosis Detection Kit I, and
the number and apoptosis of macrophages were analyzed by flow cytometry. c DEN selectively reduces the number of peritoneal macrophages in
Cd24−/− but not WT mice. Data shown are the absolute number of F4/80+ cells in the peritoneal cavity at 24 h after DEN treatment. d Representative
FACS profiles depicting apoptotic macrophages in vehicle or DEN-treated mice. e Percentages of F4/80+Annexin V+ cells in peritoneal cavity. Data are
pooled from independent experiments. The data were analyzed by Student’s t-test
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(OCT) or fixed in 10% formalin for histological staining.
The remaining liver tissues were used for isolation of liver
mononuclear cells.
Histology and immunofluorescence
The large lobes of livers were immediately embedded in
OCT, or fixed in 10% formalin and paraffin-embedded.
Sections (5.0 μm) were subjected to analysis of histological
and immunochemical staining.
To examine the accumulation of ROS, freshly prepared
frozen liver sections were incubated with 2.0 μM dihy-
droethidine (Invitrogen) for 30min at 37 °C, after which
they were observed by fluorescence microscopy and
photographed.
TUNEL assays were performed using the In Situ Cell
Death Detection Kit (Roche) on paraffin-embedded liver
sections. For double immunofluorescence staining of F4/
80 and TUNEL, frozen sections were stained with F4/80
antibody, followed by permeabilization with 1% citrate for
15min at 4 °C, and then TUNEL staining was performed
according to the manufacturer’s instructions. The
mounted slides were observed under a microscope (Leica
DM2500). The number of TUNEL-positive cells was
determined by manual counting of at least 5 high-power
fields per section.
The immunostaining on frozen liver sections was per-
formed as previously described54. Primary antibodies were
rat anti-F4/80 (Abcam, ab6640, 1/100), rabbit anti-F4/80
(Santa Cruz, sc-25830, 1/50), rat anti-CD24 (Santa Cruz,
sc-19651, 1/100), rabbit p-Histone H2AX (γ-H2AX)
(Bioworld Technology, Inc., BS4760, 1/100), goat anti-
HNF4α (Santa Cruz, sc-6556, 1/50), rabbit anti-PCNA
(Santa Cruz, sc-7907, 1/300). Secondary antibodies were
purchased from Santa Cruz and Zhongshan Goldenbridge
Biotech (Beijing, China). For microscope images, positive
cells were quantified with Image-Pro Plus 6.0 software
(Media Cybernetics, Inc.).
Cell isolation
For isolation of liver mononuclear cells, the liver frag-
ments were incubated for 30 min in 0.025% collagenase
type IV in HBSS (Gibco) at 37 °C shaking at 220 rpm. The
whole material was passed through a 70 μm cell strainer
to get a single cell suspension, centrifuged with 50 G for 3
min to remove hepatocytes. The liver mononuclear cells
were recovered from the interface of 40 and 60% percoll
(GE Healthcare) after centrifugation. The liver mono-
nuclear cells were washed and used for flow cytometry. To
enrich macrophages, mononuclear cells were suspended
in serum-free RPMI-1640 medium and were seeded into
24-well plate. After incubation for 2 h, the cells were
washed three times with PBS to remove the non-adherent
cells. The adherent cells were used as source for intra-
hepatic macrophages, and the purity of macrophages was
determined by morphology and immunofluorescence
staining with F4/80 antibody.
Peritoneal resident cells were harvested by lavage of
mouse peritoneal cavity with 2.0 mL of ice cold 3% FCS/
PBS according to the protocol as described59. The col-
lected cells were centrifuged at 1300 rpm for 10 min, and
re-suspended in RPMI-1640 medium or PBS for counting.
The cells in RPMI-1640 medium were seeded into the
wells of 24-well or 96-well plate. After incubation for 2 h,
the cells were washed three times with PBS to remove the
non-adherent cells. The adherent cells were macrophages
for cell ELISA (for p53) and RT-PCR (for p21 and puma),
or were treated with 20mM DEN for 24 h for RNA
extract (for p21 and puma). For peritoneal macrophages
by flow cytometry, the re-suspended cells in PBS were
immediately counted, washed twice in PBS, and re-
suspended in FACS buffer (2% FBS in PBS containing
0.01% NaN3).
Flow cytometry
The following antibodies were used for FACS: FITC-
anti-CD11b (11–0112), APC-anti-CD11b (17–0112), PE-
anti-F4/80 (12–4801), FITC-anti-F4/80 (11–4801), APC-
anti-CD45 (17–0451), PerCp-Cy5.5-anti-CD45 (45–0451),
FITC-anti-CD24 (11–0242), APC-anti-CD24 (17–0242),
PerCP-Cy5.5-anti-NK1.1 (45–5941), PE-anti-CD4
(12–0041), FITC-CD3e (11–0031), PerCP-Cy5.5-Gr1
(45–5931), and PE-anti-Ly6C (12–5932) obtained from
(see figure on previous page)
Fig. 7 The Cd24–p53 axis sustains macrophages during carcinogenesis. a Cell-based ELISA for p53 in macrophages. Macrophages were
obtained as described in Figure S11. The p53 protein expression in macrophages was quantitated using a target specific primary antibody and HRP-
conjugated secondary antibody detection agent, and the crystal violet provided whole cell staining that was used for cell number counts. The levels
of p53 protein were normalized by total cell counts in each well with this formula of OD450/OD595. Each dot represents mean data from one mouse
based on triplicate counts. Data from two independent experiments are presented. b Cd24 deficiency increased p21 mRNA expression after in vivo
DEN (15 μg/g) treatment. Data from three independent experiments are pooled. c As in b, except that WT and Cd24−/− macrophages were treated
with 20 mM DEN in vitro. Data from two independent experiments are pooled. Statistical significance was determined by student’s t-test. d F4/
80 staining for liver macrophages in DEN-treated mice. Cd24+/+Trp53+/+, Cd24−/−Trp53+/+, Cd24+/+Trp53−/−, and Cd24−/−Trp53−/−. Scale bar = 100 μm. e
Integrated optical density of F4/80-positive cells quantified by Image-Pro Plus 6.0 software in a lower-power field of a microscopy. Twenty fields in
each section were counted. Data from multiple experiments are presented. Statistical significances were analyzed by Student’s t-test
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eBioScience, and PE Annexin V Apoptosis Detection Kit I
(559763) from BD Pharmingen. Cells were blocked for 15
min with Fc blocking reagent on ice prior to labeled with
fluorescent-conjugated antibodies diluted in FACS buffer.
Cells for phenotypic analyses were stained using the
indicated fluorescent-conjugated antibody for 30 min on
ice. Appropriate isotype controls were used in all case.
Flow cytometry was performed using a FACSCalibur (BD
Bioscience, San Jose, CA) and the data were analyzed with
FlowJo software (TreeStar, Ashland, OR).
Macrophage depletion
To deplete macrophages,13-day-old mice were injected
i.p. with 70 μl of liposomal clodronate (5 mg/ml clo-
dronate) and liposomal control (no clodronate) (Encap-
sula NanoSciences LLC). Fourty-eight hours later, the
mice were treated with DEN. In some experiments, mice
were killed 24 h after DEN administration for analysis of
apoptosis. For the tumor initiation model, mice were kept
for additional 5 months, after which they were killed and
analyzed to determine tumor load. Depletion of liver
macrophages was assessed 72 h after clodronate admin-
istration by immunohistochemical staining of frozen liver
sections with F4/80 antibody, and RT-PCR analysis of F4/
80 mRNA levels.
To deplete liver macrophages after tumor already
formed, WT mice were injected with 15 μg/g DEN at 15-
day of ages. After 5 months, 200 μL of 1:1 PBS-diluted
liposomes were injected via the vail vein once every 5 days
for 3 times. All mice were killed 1 month after the last
injection.
RNA extraction and RT-PCR
Total RNA was isolated from adherent peritoneal or
liver macrophages using the miRNeasy Mini Kit (Qiagen)
according to the manufacturer’s protocol. cDNA was
synthesized using total RNA via PrimeScript RT reagent
Kit with gDNA Eraser (Takana) according to the manu-
facturer’s instructions. Real-time PCR was performed
using SYBR green PCR master mix (Applied Biosystem,
USA) in a 7500 Real-Time PCR System (ABI). Expression
levels of evaluated genes were calculated with the com-
parative ΔCt method using hypoxanthine guanine phos-
phoribosyl transferase as a reference gene, and relative
abundance was quantified with the 2-ΔΔCt method. The
following forward and reverse specific primer sequences
were used: Il1b-F (TGAAGCAGCTATGGCAACTG),
Il1b-R (AGGTCAAAGGTTTG GAAGCA); Il-6-F (GA
GGATACCACTCCCAACAGACC), Il-6-R (AAGTG
CATCA TCGTTGTTCATACA); Tnfa-F (CAGCCT
CTTCTCATTCCTGC), Tnfa-R (GGTC TGGGCCATAG
AACTGA); Mcp-1-F (TGCATCTGCCCTAAGGTCT
TC), Mcp-1-R (AAGTGCTTGAGGTGGTTGTGG);
p21-F (CGAGAACGGTGGAACTTTGACT), p21-R
(GGACCCAGGGCTCAGGTAGAC); puma-F (ACC
TCAACGCGCAGTACGA), puma-R (GGGAGGAGT
CCCATGAAGAGA); Emr1-F (ACTGTGGAAAGCAC
CATG TTAGC), Emr1-R (TTTCGATGTCTAGGT
ACTCCGTC); iNOS-F (TGAAGAAA ACCCCTTG
TGCT), iNOS-R (TTCTGTGCTGTCCCAGTGAG);
Hprt-F (ATGAG CGCAAGTTGAATCTG), Hprt-R
(CAGATGGCC ACAGGACTAGA).
Cell-based ELISA for p53 in macrophages
The p53 protein expression in macrophages was
quantitatively determined using Total p53 Cell-Based
Colorimetric ELISA Kit (ImmunoWay, USA) according to
the manufacturer’s instructions. In brief, isolated macro-
phages in a 96-well plate in triplicate were fixed in 4%
formaldehyde for 30 min. Each well was incubated with
anti-p53 antibody overnight at 4 °C. After washing three
times with wash buffer, samples were incubated with
HRP-conjugated secondary antibody followed by incuba-
tion with TMB substrate. Read the absorbance at 450 nm
after adding stop solution. Crystal violet binds to cell
nuclei and gives absorbance reading at 595 nm that is
proportional to cell numbers. After washing the plate
several times, each well was stained with the crystal violet
solution, after which the absorbance at 595 nm was
measured. The levels of p53 protein were normalized by
total cell number in each well with this formula of
OD450/OD595.
Protein preparation and western blot
Total proteins were isolated from frozen liver tissues
after homogenization in RIPA buffer supplemented with
proteinase inhibitor protease (cocktail and PMFS) and
phosphatase inhibitors (Na3VO4, BETA-glycerophosphate
and Na2P2O4) on ice. Protein from tissue lysate was
quantified using the DC Protein Assay Kit (Bio-Rad).
Equal amounts of protein were used for western blots and
cytokine measurement. Western blot was performed
according to standard protocols. Lysed proteins were
separated using 10% SDS/PAGE and transferred to poly-
vinylidene difluoride membranes (Millipore). Membranes
were exposed to antibodies that recognized STAT3 (CST,
no. 4904), P-STAT3 (CST, no. 9145), and β-actin (Bio-
world, no. AP0060). The β-actin was used as an internal
control to normalize the loading materials.
Cytokine determination
Cytokines were measured from serum and liver lysate
using Mouse Enhanced Sensitivity Flex Set from BD
Cytometric Bead Array (CBA, BD Biosciences) according
to the manufacturer’s instructions. CBA for IL-1β, IL-6,
TNF, IL-17A, and IFN-γ were carried out, and data were
acquired on FACS AriaII (BD Bioscience, San Jose, CA).
Serum levels of HMGB1 were measured using
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commercial kits (BIOPCR, H20734) according to the
manufacturer’s protocol.
Statistical analysis
The differences in mean values between groups were
analyzed by a two-tailed unpaired Independent-Samples
t-test unless otherwise indicated. For tumor volume
comparison, the total tumor volumes in mice were pre-
sented as a logarithmic distribution. After the log10
transformation, the volumes for different subgroups were
presented in a normal distribution (p> 0.05 in a One-
Sample Kolmogorov–Smirnov test). Then, the difference
in mean log volumes between mice with WT and
Cd24−/− genotypes was analyzed by Student’s t-test.
These statistical analyses were performed with the
GraphPad Prism 5 Software (GraphPad, San Diego, CA)
and SPSS19.0 Software (SPSS, Chicago, USA). Data are
presented as means or means± SEM. A result was
considered significant if a p-value was <0.05 (*p< 0.05,
**p< 0.01, ***p< 0.001).
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